Roche drug cocktail doubles chance of halting lung cancer
Mail Online -

By John MillerZURICH, Dec 7 (Reuters) - Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a...

Loading...

Related Articles